STOCKWATCH
·
Biotechnology
Quarterly Result9 May 2026, 03:30 pm

Advanced Enzyme Tech FY26 Revenue Up 17% to ₹7,458 Mn

AI Summary

Advanced Enzyme Technologies Ltd announced its audited financial results for Q4 and the year ended March 2026. Consolidated revenue for FY26 increased by 17% to ₹7,458 million. Q4 FY26 revenue stood at ₹2,034 million, a 22% increase YoY. EBITDA for Q4 FY26 was ₹632 million, up 39% YoY, with an EBITDA margin of 31%. PAT for Q4 FY26 grew by 69% to ₹453 million, with a PAT margin of 22%. EPS for Q4 FY26 was ₹3.84, compared to ₹2.37 in Q4 FY25.

Key Highlights

  • Q4 FY26 revenue increased by 22% YoY to ₹2,034 million.
  • Q4 FY26 EBITDA grew by 39% YoY to ₹632 million, with a 31% margin.
  • Q4 FY26 PAT increased by 69% YoY to ₹453 million, with a 22% margin.
  • FY26 revenue from operations increased by 17% to ₹7,458 million.
  • Domestic sales grew by 51% YoY, accounting for 52% of Q4 FY26 revenue.
View BSE Filing